Invasive pulmonary aspergillosis due to Aspergillus terreus: Value of DNA, galactomannan and (1→3)-β-D-glucan detection in serum samples as an adjunct to diagnosis

Journal of Medical Microbiology

Volumn 59, Issue 12, 2010, Pages 1519-1523

  Mokaddas, E ^a   Burhamah, M H A ^b   Ahmad, S ^a   Khan, Z U ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ASPARAGINASE; BETA 1,3 GLUCAN; BIOLOGICAL MARKER; CYTARABINE; DEXAMETHASONE; EPIRUBICIN; FUNGAL DNA; GALACTOMANNAN; IMATINIB; METHOTREXATE; RIBOSOME DNA; VINCRISTINE; VORICONAZOLE;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS TERREUS; BACTERIAL PNEUMONIA; BLOOD LEVEL; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE MARKER; FATALITY; FUNGAL DETECTION; FUNGUS ISOLATION; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG ASPERGILLOSIS; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEPTICEMIA; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIFUNGAL AGENTS; BETA-GLUCANS; CHILD; HUMANS; LUNG DISEASES, FUNGAL; MALE; MANNANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PULMONARY ASPERGILLOSIS; PYRIMIDINES; TRIAZOLES;

EID: 78649409114     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.023630-0     Document Type: Article

References (34)

1. Ahmad, S., Khan, Z. U. & Theyyathel, A. M. (2007). Diagnostic value of DNA, (1-3)-β-D-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn Microbiol Infect Dis 59, 165-171. (Pubitemid 47496092)
2. Baddley, J. W., Pappas, P. G., Smith, A. C. & Moser, S. A. (2003). Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41, 5525-5529.
3. Blum, G., Perkhofer, S., Grif, K., Mayr, A., Kropshofer, G., Nachbaur, D., Kafka-Ritsch, R., Dierich, M. P. & Lass-Flörl, C. (2008). A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 14, 1146-1151.
4. Castón, J. J., Linares, M. J., Gallego, C., Rivero, A., Font, P., Solís, F., Casal, M. & Torre-Cisneros, J. (2007). Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest 131, 230-236. (Pubitemid 46122998)
5. Curtis, L., Cali, S., Conroy, L., Baker, K., Ou, C. H., Hershow, R., Norlock-Cruz, F. & Scheff, P. (2005). Aspergillus surveillance project at a large tertiary-care hospital. J Hosp Infect 59, 188-196. (Pubitemid 40197780)
6. Deak, E., Wilson, S. D., White, E., Carr, J. H. & Balajee, S. A. (2009). Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS ONE 4, e7673.
7. Guinea, J., Peláez, T., Alcalá, L. & Bouza, E. (2006). Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 44, 349-356. (Pubitemid 43922070)
8. Hachem, R. Y., Kontoyiannis, D. P., Boktour,M. R., Afif, C., Cooksley, C., Bodey, G. P., Chatzinikolaou, I., Perego, C., Kantarjian, H. M. & Raad, I. I. (2004). Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101, 1594-1600. (Pubitemid 39318906)
9. Hachem, R. Y., Kontoyiannis, D. P., Chemaly, R. F., Jiang, Y., Reitzel, R. & Raad, I. (2009). Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47, 129-133.
10. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P. & other authors (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408-415.
11. Kedzierska, A., Kochan, P., Pietrzyk, A. & Kedzierska, J. (2007). Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis 26, 755-766. (Pubitemid 47573385)
12. Khan, Z. U., Khan, M. A., Chandy, R. & Sharma, P. N. (1999a). Aspergillus and other moulds in the air of Kuwait. Mycopathologia 146, 25-32. (Pubitemid 30124507)
13. Khan, Z. U., Kortom, M., Marouf, R., Jamal, W. & Chandy, R. (1999b). Fatal pulmonary aspergillosis due to Aspergillus terreus. J Mycol Med 9, 166-169. (Pubitemid 29508008)
14. Khan, Z. U., Kortom, M., Marouf, R., Chandy, R., Rinaldi, M. G. & Sutton, D. A. (2000). Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus. J Clin Microbiol 38, 2010-2014. (Pubitemid 30253960)
15. Khan, Z. U., Ahmad, S., Mokaddas, E., Said, T., Nair, M. P., Halim, M. A., Nampoory, M. R. & McGinnis, M. R. (2007). Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1→3)-β-D-glucan in clinical specimens. J Med Microbiol 56, 129-132. (Pubitemid 46036285)
16. Khan, Z. U., Ahmad, S. & Theyyathel, A. M. (2008). Detection of Aspergillus fumigatus-specific DNA, (1-3)-β-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses 51, 129-135. (Pubitemid 351191118)
17. Koo, S., Bryar, J. M., Baden, L. R. & Marty, F. M. (2010). Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 48, 1255-1260.
18. Lass-Flörl, C., Kofler, G., Kropshofer, G., Hermans, J., Kreczy, A., Dierich, M. P. & Niederwieser, D. (1998). In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42, 497-502.
19. Lass-Flörl, C., Griff, K., Mayr, A., Petzer, A., Gastl, G., Bonatti, H., Freund, M., Kropshofer, G., Dierich, M. P. & Nachbaur, D. (2005). Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131, 201-207. (Pubitemid 43899686)
20. Lass-Flörl, C., Alastruey-Izquierdo, A., Cuenca-Estrella, M., Perkhofer, S. & Rodriguez-Tudela, J. L. (2009). In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 53, 794-795.
21. Marty, F. M. & Koo, S. (2009). Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis. Med Mycol 47, S233-S240.
22. Mennink-Kersten, M. A., Ruegebrink, D., Wasei, N., Melchers, W. J. & Verweij, P. E. (2006). In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44, 1711-1718.
23. Obayashi, T., Negishi, K., Suzuki, T. & Funata, N. (2008). Reappraisal of the serum (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin Infect Dis 46, 1864-1870.
24. Ostrosky-Zeichner, L. (2008). Biomarkers for diagnosis and disease monitoring. J Invasive Fungal Infect 2, 242-245.
25. Pazos, C., Pontón, J. & Del Palacio, A. (2005). Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43, 299-305. (Pubitemid 40096315)
26. Pickering, J. W., Sant, H. W., Bowles, C. A., Roberts, W. L. & Woods, G. L. (2005). Evaluation of a (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43, 5957-5962.
27. Sanguinetti, M., Posteraro, B., Pagano, L., Pagliari, G., Fianchi, L., La Sorda, M., Franco, A. & Fadda, G. (2003). Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 41, 3922-3925.
28. Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J. & other authors (2008). 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46, 878-885. (Pubitemid 351417190)
29. Sherif, R. & Segal, B. H. (2010). Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med 16, 242-250.
30. Steinbach, W. J., Benjamin, D. K., Jr, Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H. & other authors (2004). Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39, 192-198. (Pubitemid 38971489)
31. Sutton, D. A., Sanche, S. E., Revankar, S. G., Fothergill, A. W. & Rinaldi, M. G. (1999). In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 37, 2343-2345.
32. Vandewoude, K. H., Blot, S. I., Depuydt, P., Benoit, D., Temmerman, W., Colardyn, F. & Vogelaers, D. (2006). Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10, R31. (Pubitemid 47079790)
33. Vonberg, R. P. & Gastmeier, P. (2006). Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63, 246-254.
34. Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J. & other authors (2008). Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46, 327-360. (Pubitemid 351265310)